Skip to main content
Back
Watch Compare

United Health Products, Inc.

Data quality: 100%
UEEC
OTC Manufacturing Measuring & Analyzing Instruments
$0.05
▼ $0.00 (-4.08%)
Mkt Cap: 12.68 M
Price
$0.05
Mkt Cap
12.68 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -815,253.0

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.02
Interest Coverage-32.29

Valuation

PE (TTM)
-3.31
Below sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -3.3 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -3.83 M
ROE N/A ROA -4356.54%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -815,253.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.02
Interest Coverage -32.29 Asset Turnover 0.00
Working Capital -1.96 M Tangible Book Value -3.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.31 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -6.43%
Market Cap 12.68 M Enterprise Value 13.60 M
Per Share
EPS (Diluted TTM) -0.02 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 21.28%
SBC-Adj. FCF -815,253 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 0.0 37,500.0 59.0 643.0
Net Income -2.00 M -2.62 M -1.69 M -30.55 M -15.71 M
EPS (Diluted) -0.01 — — — —
Gross Profit — 0.0 18,856.0 34.0 448.0
Operating Income -2.01 M -2.43 M -2.80 M -29.80 M -14.85 M
EBITDA — — — — —
R&D Expenses 355,936.0 598,810.0 624,564.0 237,458.0 245,218.0
SG&A Expenses 1.65 M 1.83 M 2.20 M 29.56 M 14.60 M
D&A 4,050.0 4,050.0 — — —
Interest Expense 32,322.0 40,512.0 17,022.0 226,139.0 210,025.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 269,979.0 284,643.0 350,528.0 26,799.0 217,100.0
Total Liabilities 2.71 M 2.00 M 2.42 M 1.17 M 1.17 M
Shareholders' Equity -2.44 M -1.71 M -2.06 M -1.14 M -953,262.0
Total Debt — — — — —
Cash & Equivalents — — 13,377.0 21,799.0 46,076.0
Current Assets 191,683.0 151,822.0 71,039.0 26,799.0 115,750.0
Current Liabilities 1.64 M 1.95 M 2.42 M 1.17 M 1.17 M